Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients
Background: Drug-drug interactions (DDIs) are a major but preventable cause of adverse drug reactions. There is insufficient information regarding DDIs in lung transplant recipients.Objective: This study aimed to determine the prevalence of potential DDIs (pDDIs) in intensive care unit (ICU) lung tr...
Main Authors: | Jiali Zhang, Danyi Ma, Meng Chen, Yanting Hu, Xveying Chen, Jingyu Chen, Man Huang, Haibin Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1308260/full |
Similar Items
-
The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
by: Yi-Chang Zhao, et al.
Published: (2022-12-01) -
Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient
by: Julia Concha, et al.
Published: (2023-07-01) -
Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01) -
A case report of drug interaction between co-packaged nirmatrelvir-ritonavir and tacrolimus causing hyponatremia in a lung transplant recipient
by: Chien-Ming Lo, et al.
Published: (2024-03-01) -
Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients
by: Guangxiang Gu, et al.
Published: (2023-10-01)